Safety and Efficacy Evaluation of Remimazolam for Endoscopic Ultrasound-guided Fine Needle Aspiration/Biopsy
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
This study aims to compare the safety and efficacy of remimazolam and propofol in EUS-FNA/FNB
sedation. This study is a prospective, single-blind study. We plan to enroll 264 patients
undergoing EUS-FNA and divide them into two groups. The experimental group was sedated with
remimazolam, and the control group was sedated with propofol; safety and efficacy parameters
such as intraoperative blood pressure, finger pulse oxygen, heart rate and sedation success
rate would be compared. We hypothesized that patients in the experimental group would be
superior in terms of safety parameters; the two would be equal in terms of sedation success.
Phase:
N/A
Details
Lead Sponsor:
The Third Xiangya Hospital of Central South University